BlackBarn Capital Partners LP — 13F Holdings & Portfolio
CIK 2010204 · latest 13F-HR filed 2026-08-14
BlackBarn Capital Partners LP manages $1.19B in 13F-reported U.S. long-equity assets across 24 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPY (50.40%), ROIV (5.97%), OSCR (4.21%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 5 new positions and exited 2; 9 existing positions rose in reported value and 3 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 81.4%Cumulative share of the portfolio held in the largest N positions.
25TH FLOOR
NEW YORK, NY 10019
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| BLACKBARN CAPITAL PARTNERS GP, LLC Control | GENERAL PARTNER | Less than 5% | Domestic Entity |
| CARTER, JONATHAN, LARRABEE Control | LIMITED PARTNER | 75% or more | Individual |
| CARTER, JONATHAN, LARRABEE Control | MANAGING MEMBER | 75% or more | Individual |
| CLEMENS, JAMES, CHARLES Control | LIMITED PARTNER | 10–25% | Individual |
| EDELSTEIN, JEREMY, JASON Control | COO, CFO, CCO | Less than 5% | Individual |
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- NXP SEMICONDUCTORS N V$13.5M +114.1%
- PRIVIA HEALTH GROUP INC$8.2M +25.1%
- ROIVANT SCIENCES LTD$7.5M +11.8%
- DIVERSIFIED HEALTHCARE TR$5.9M +18.6%
- NIQ GLOBAL INTELLIGENCE PLC$3.6M +15.1%
Top Trims
- COGENT COMMUNICATIONS HLDGS-$6.0M -63.2%
- MCGRAW HILL INC-$5.4M -18.9%
- NEXTERA ENERGY INC-$1.7M -5.5%
New Positions
- UNITEDHEALTH GROUP INC$27.0M
- VENTURE GLOBAL INC$19.5M
- AZUL S A$15.1M
- OCCIDENTAL PETE CORP$12.1M
- CALIFORNIA RES CORP$9.3M
BlackBarn Capital Partners LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR Put | SPY | 78462F103 | $597.4M | 50.40% | 800,000 | SH |
| 2 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $70.8M | 5.97% | 2,000,000 | SH |
| 3 | OSCAR HEALTH INC Put | OSCR | 687793109 | $49.9M | 4.21% | 1,750,000 | SH |
| 4 | UNITEDHEALTH GROUP INC Call | UNH | 91324P102 | $41.6M | 3.51% | 100,000 | SH |
| 5 | PRIVIA HEALTH GROUP INC | PRVA | 74276R102 | $40.8M | 3.44% | 1,585,000 | SH |
| 6 | RESMED INC Put | RMD | 761152107 | $39.0M | 3.29% | 200,000 | SH |
| 7 | DIVERSIFIED HEALTHCARE TR | DHC | 25525P107 | $37.9M | 3.20% | 4,075,000 | SH |
| 8 | VENTURE GLOBAL INC Call | VG | 92333F101 | $33.4M | 2.82% | 3,000,000 | SH |
| 9 | NEXTERA ENERGY INC | NEE | 65339F101 | $29.4M | 2.48% | 335,000 | SH |
| 10 | NIQ GLOBAL INTELLIGENCE PLC | NIQ | G63755105 | $27.2M | 2.29% | 2,903,862 | SH |
| 11 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $27.0M | 2.28% | 65,000 | SH |
| 12 | NXP SEMICONDUCTORS N V | NXPI | N6596X109 | $25.3M | 2.13% | 90,000 | SH |
| 13 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $23.4M | 1.97% | 600,000 | SH |
| 14 | MCGRAW HILL INC | MH | 580907103 | $23.2M | 1.96% | 2,450,000 | SH |
| 15 | AMNEAL PHARMACEUTICALS INC | AMRX | 03168L105 | $22.5M | 1.90% | 1,300,000 | SH |
| 16 | VENTURE GLOBAL INC | VG | 92333F101 | $19.5M | 1.64% | 1,750,000 | SH |
| 17 | AZUL S A | AZUL | 05501U601 | $15.1M | 1.28% | 1,684,188 | SH |
| 18 | OCCIDENTAL PETE CORP | OXY | 674599105 | $12.1M | 1.02% | 250,000 | SH |
| 19 | WARBY PARKER INC Put | WRBY | 93403J106 | $12.1M | 1.02% | 400,000 | SH |
| 20 | ARBUTUS BIOPHARMA CORP | ABUS | 03879J100 | $12.0M | 1.01% | 2,500,000 | SH |
| 21 | VIKING THERAPEUTICS INC Call | VKTX | 92686J106 | $9.8M | 0.82% | 250,000 | SH |
| 22 | CALIFORNIA RES CORP | CRC | 13057Q305 | $9.3M | 0.78% | 175,000 | SH |
| 23 | COGENT COMMUNICATIONS HLDGS | CCOI | 19239V302 | $3.5M | 0.29% | 250,000 | SH |
| 24 | VIVID SEATS INC | SEAT | 92854T209 | $3.3M | 0.28% | 500,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $1.19B | 24 | 0002010204-26-000006 |
| 2026-03-31 | 2026-05-15 | $1.24B | 21 | 0002010204-26-000004 |
| 2025-12-31 | 2026-02-17 | $1.52B | 16 | 0002010204-26-000001 |
| 2025-09-30 | 2025-11-14 | $1.40B | 20 | 0002010204-25-000006 |
25TH FLOOR
NEW YORK, NY 10019